20/20 Gene Systems (Convertible Notes)

Funding Details
Awarder
StartEngine
Date Award
June 13, 2024
Vertical
Healthcare
Funding URL
View Funding Page
Premoney Valuation
$58,400,000
Valuation
$58,400,000

Company Info
Founding Year
Not provided
Traction
This represents an increase of more than 300% over 2020 revenues. With their ability to enhance their operations with COVID testing, they ranked no. 131 on the Inc. 5000 list of America’s fastest-growing companies in 2022.
Revenue Amount
$30,000,000
Organizations Involved
China’s Ping An Ventures, Keiretsu Forum, family offices, over 8,000 crowd investors
Founders
Jonathan Cohen, Jiming Zhou, Michael Lebowitz
Company Description
20/20 GeneSystems (‘20/20’) was founded in May of 2000 to develop and promote an innovative proteomics product line that provides drug
Market
Medical Diagnostics
Location
Gaithersburg, MD, US
Coinvestors
China’s Ping An Ventures, Keiretsu Forum, family offices, over 8,000 crowd investors

Links